Pneumonia Prophylaxis for Cancer Patients during Chemotherapy.

Pathogens

Cancer Center, Ehime University Hospital, Toon, Ehime 7910295, Japan.

Published: February 2021

pneumonia (PJP) is one type of life-threatening pneumonia in immunocompromised patients. PJP development should be considered in not only immunocompromised individuals, but also patients undergoing intensive chemotherapies and immunotherapies, organ transplantation, or corticosteroid treatment. Past studies have described the clinical manifestation of PJP in patients during chemotherapy and reported that PJP affects cancer treatment outcomes. Therefore, PJP could be a potential problem for the management of cancer patients during chemotherapy, and PJP prophylaxis would be important during cancer treatment. This review discusses PJ colonization in outpatients during cancer chemotherapy, as well as in healthy individuals, and provides an update on PJP prophylaxis for cancer patients during chemotherapy.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923143PMC
http://dx.doi.org/10.3390/pathogens10020237DOI Listing

Publication Analysis

Top Keywords

patients chemotherapy
16
prophylaxis cancer
12
cancer patients
12
cancer treatment
8
pjp prophylaxis
8
pjp
7
cancer
6
patients
6
chemotherapy
5
pneumonia prophylaxis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!